Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ijd.15553 | DOI Listing |
Publication Analysis
Top Keywords
association chilblain
4
chilblain lupus
4
lupus anti-ro/ssa
4
anti-ro/ssa anti-la/ssb
4
anti-la/ssb antibodies
4
antibodies study
4
study cases
4
association
1
lupus
1
anti-ro/ssa
1
Similar Publications
Chilblain lupus erythematosus associated with erdafitinib therapy in a patient with metastatic bladder cancer.
JAAD Case Rep
December 2024
Department of Dermatology, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California.
Systemic complications of Aicardi Goutières syndrome using real-world data.
Mol Genet Metab
October 2024
Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address:
Article Synopsis
- Aicardi Goutières Syndrome (AGS) is a rare genetic disorder characterized by a range of systemic health issues and delayed diagnosis, prompting researchers to analyze longitudinal data from medical records to better understand its burden.* -
- The study included 167 individuals with genetically confirmed AGS, compiling information on demographics, age of onset, and neurological complications; the most frequent genetic mutations associated with AGS were identified.* -
- Results revealed that gastrointestinal issues were the earliest systemic complications, while neurological symptoms such as tone abnormalities and irritability were prevalent, usually manifesting in infancy.*
Chilblain lupus erythematosus triggered by UV nail lamp exposure: A case series. .
Lupus
October 2024
Hospital Militar Central, Bogotá, Colombia.
Article Synopsis
- - Two cases of chilblain lupus erythematosus (CLE) were reported that may have been triggered by ultraviolet (UV) nail lamps.
- - The cases, alongside existing literature, indicate a potential connection between the use of UV nail lamps and the development or reactivation of CLE.
- - More research is necessary to verify this link, but healthcare providers should be cautious about the risks associated with UV nail lamps, particularly for patients with conditions sensitive to light.
Prevalence of skin manifestations in patients with COVID-19: a systematic review and meta-analysis.
Front Med (Lausanne)
August 2024
Health Science Graduate Program, School of Health Sciences, University of Brasilia, Brasília, Brazil.
Article Synopsis
- This systematic review aimed to analyze the prevalence and characteristics of skin manifestations associated with COVID-19, as these can assist in diagnosis, especially since the details were unclear.
- The review included 31 studies with over 10,000 patients and found that the overall prevalence of skin manifestations was about 29%, predominantly observed in Africa, with hands, feet, and trunk being most affected.
- Patients with milder COVID-19 symptoms showed more specific skin conditions compared to those with severe cases, indicating that skin assessments should be a key part of evaluating and diagnosing COVID-19, particularly in adults and the elderly.
Hereditary C1q Deficiency is Associated with Type 1 Interferon-Pathway Activation and a High Risk of Central Nervous System Inflammation.
J Clin Immunol
August 2024
Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, INSERM UMR1163, Paris, France.
Article Synopsis
- Hereditary C1q deficiency (C1QDef) is a rare genetic disorder that disrupts the complement system and can cause symptoms similar to systemic lupus erythematosus (SLE).
- A study of 12 genetically confirmed C1QDef patients showed elevated expression of interferon-stimulated genes and high levels of interferon alpha in their blood and cerebrospinal fluid, indicating significant immune dysfunction.
- Treatment with Janus-kinase inhibitors had mixed results, with one patient improving while others continued to struggle with their condition, highlighting the complexity of managing C1QDef.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!